Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The risk of lymphoma may be increased by about fourfold in patients with inflammatory bowel disease treated with thiopurines. The increased risk could be a result of the medications, the severity of the underlying disease, or a combination of the two.

Original publication

DOI

10.1136/gut.2004.053231

Type

Journal article

Journal

Gut

Publication Date

08/2005

Volume

54

Pages

1055 - 1059

Keywords

Antimetabolites, Azathioprine, Humans, Inflammatory Bowel Diseases, Lymphoma, Risk Factors, Severity of Illness Index